These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 3005756
21. CRH test prior to discontinuation of long-term low-dose glucocorticoid therapy. Gellner R, Stange M, Schiemann U, Domschke W, Hengst K. Exp Clin Endocrinol Diabetes; 1999; 107(8):561-7. PubMed ID: 10612488 [Abstract] [Full Text] [Related]
22. The effect of alternate-day prednisone therapy on cortisol secretion rate in corticosteroid-dependent asthmatics. Bakran I, Korsić M, Duraković Z, Vrhovac B, Tajić M. Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):57-60. PubMed ID: 328415 [Abstract] [Full Text] [Related]
23. Duration of pituitary and adrenocortical suppression after long-term administration of anti-inflammatory doses of prednisone in dogs. Moore GE, Hoenig M. Am J Vet Res; 1992 May; 53(5):716-20. PubMed ID: 1326243 [Abstract] [Full Text] [Related]
24. Risk of relapse in steroid-sensitive nephrotic syndrome: effect of stage of post-prednisone adrenocortical suppression. Leisti S, Koskimies O. J Pediatr; 1983 Oct; 103(4):553-7. PubMed ID: 6312005 [Abstract] [Full Text] [Related]
25. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland. Lamberts SW, Zuiderwijk J, Uitterlinden P, Blijd JJ, Bruining HA, de Jong FH. J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930 [Abstract] [Full Text] [Related]
26. The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal function. Ambroziak U, Bluszcz G, Bednarczuk T, Miśkiewicz P. Endokrynol Pol; 2017 Jan; 68(4):430-433. PubMed ID: 28604944 [Abstract] [Full Text] [Related]
27. Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report. De Bellis A A, Falorni A, Laureti S, Perrino S, Coronella C, Forini F, Bizzarro E, Bizzarro A, Abbate G, Bellastella A. J Clin Endocrinol Metab; 2001 Feb; 86(2):675-8. PubMed ID: 11158030 [Abstract] [Full Text] [Related]
29. Adrenocortical suppression in dogs on daily and alternate-day prednisone administration. Chastain CB, Graham CL. Am J Vet Res; 1979 Jul; 40(7):936-41. PubMed ID: 507496 [Abstract] [Full Text] [Related]
30. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Hensen J, Buhl M, Bähr V, Oelkers W. Klin Wochenschr; 1990 Jun 19; 68(12):608-14. PubMed ID: 2165544 [Abstract] [Full Text] [Related]
31. Adrenal suppression with cushingoid features from inhaled corticosteroid therapy in an adult asthmatic patient. Tsoukas MA, Krishnamoorthy P, Richards BJ, Pepe C, Christopoulos S. Am J Med; 2014 May 19; 127(5):e1-2. PubMed ID: 24412770 [No Abstract] [Full Text] [Related]
32. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Am J Med; 1985 Nov 19; 79(5):596-604. PubMed ID: 4061472 [Abstract] [Full Text] [Related]
33. Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: possible contribution for the autonomous production of cortisol. Imai T, Sarkar D, Shibata A, Funahashi H, Morita-Matsuyama T, Kikumori T, Ohmori S, Seo H. Ann Surg; 2001 Jul 19; 234(1):85-91. PubMed ID: 11420487 [Abstract] [Full Text] [Related]
34. [Effect of topical glucocorticoids on endogenous cortisol production]. Neumann RA, Schmidt JB, Spona J. Z Hautkr; 1988 Apr 15; 63(4):302-8. PubMed ID: 3291439 [Abstract] [Full Text] [Related]
35. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy. Tung SC, Wang PW, Huang TL, Lee WC, Chen WJ. J Endocrinol Invest; 2004 Apr 15; 27(4):375-9. PubMed ID: 15233560 [Abstract] [Full Text] [Related]
36. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders. Nakahara M, Shibasaki T, Shizume K, Kiyosawa Y, Odagiri E, Suda T, Yamaguchi H, Tsushima T, Demura H, Maeda T. J Clin Endocrinol Metab; 1983 Nov 15; 57(5):963-8. PubMed ID: 6311867 [Abstract] [Full Text] [Related]
37. Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Cade R, Spooner G, Schlein E, Pickering M, DeQuesada A, Holcomb A, Juncos L, Richard G, Shires D, Levin D, Hackett R, Free J, Hunt R, Fregly M. Nephron; 1973 Nov 15; 10(1):37-56. PubMed ID: 4695164 [No Abstract] [Full Text] [Related]
38. Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Joffe RT, Denicoff KD, Rubinow DR, Tsokos G, Balow JE, Pillemer SE. Gen Hosp Psychiatry; 1988 Jan 15; 10(1):56-60. PubMed ID: 3345908 [Abstract] [Full Text] [Related]
39. [Pituitary adrenocortical response to high dose administration of betamethasone in neurosurgical patients (author's transl)]. Ohkubo T, Kubo O, Jimbo M, Kitamura K, Demura H, Demura R, Shizume K. No To Shinkei; 1980 Jun 15; 32(6):593-9. PubMed ID: 6257262 [Abstract] [Full Text] [Related]
40. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H. J Clin Endocrinol Metab; 1995 Aug 15; 80(8):2336-41. PubMed ID: 7629226 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]